Antiphospholipid antibody syndrome: Literature review;Sindrome dos anticorpos antifosfolipidios: Revisao bibliografica

Anais Brasileiros de Dermatologia

Volumn 75, Issue 2, 2000, Pages 219-224

  Mulinari Brenner, Fabiane Andrade ^a,d   Dal Pizzol, Ana Silvia ^a   Manfrinato, Luciana Christina ^a   Santamaria, Jesus Rodriguez ^b   Gemelli, Jair José ^c  

^a Hospital de Clínicas   (Brazil)

^b Dermatol Int Medicine Department

^c School of Medicine

^d NONE   (Brazil)

Author keywords

Abortion; Antiphospholipid syndrome; Autoimmune diseases; Skin diseases; Thrombosis; Ulcer

Indexed keywords

CARDIOLIPIN ANTIBODY; CHLORPROMAZINE; CLOZAPINE; HYDRALAZINE; LUPUS ANTICOAGULANT; PHENYTOIN; PHOSPHOLIPID ANTIBODY; PROCAINAMIDE; QUINIDINE; STREPTOMYCIN;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC PROCEDURE; HUMAN; SKIN MANIFESTATION; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; VEIN THROMBOSIS;

EID: 0033920670     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wassermann A. Uber die Entwicklung und den gegenwartigen Stand der Serodiagnostik gegenuber syphilis. Berl Klin Wochenschr 1907;44:1599.
2. Moore JE, Lutz WB. The natural history of systemic lupus erythemaosus: an approach to its study through chronic biologic false positive reactors. J Chron Dis 1955;1:297-316.
3. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 1997;81(1):151-75.
4. Nahass GT, Louis St Missouri. Antiphospholipid antibodies and the anthiphospholipid antibodies syndrome. J Am Acad Dermatol 1997;36(2):149-68.
5. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995;99:473-9.
6. McNeil HP, Simpson RJ, Chesterman CN et al. Antiphospholipid antibodies are directed against a complex antigens that includes a lipid-binding inhibitors of coagulations: beta 2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
7. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-9.
8. Henry ML, Emerson B, Ratnoff OD. Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein 1. J Lab Clin Med 1988;111:519-23.
9. Nimpf J, Wurm H, Kostner GM. Beta 2-glycoprotein 1 (apo H) inhibits the release reaction of human platelets during ADP-induces agregation. Atherosclerosis 1987;63:109-14.
10. Nimpf J, Bevers EM, Bomans PHH et al. Prothrombinase activity of human platelets in inhibited by beta 2-glycoprotein 1. Biochem Biophys Acta 1986;884:142-9.
11. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Deleze M et al. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome: relationship to reactivity of anticardiolipin antibody with thrombomodulin. J Rheumatol 1989;16:381-3.
12. Oosting JD, Derksen RHWM, Bobbink IWG et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism. Blood 1993:81:2618-25
13. Guyton AC. Lipid metabolism. In: Wonsiewicz MJ. Textbook of medical physiology. Philadelphia: WB Saunders, 1991:754-64.
14. Downing DT , Stewart ME, Wertz PW et al. Lipids of the epidermis and the sebaceous glands. In: Fitzpatrisk TB, Eisen AZ, Wolff K et al., ed. Dermatology in General Medicine. New York: McGraw-Hill, 1993:210-21.
15. Lo SCL, Oldmeadow MJ, Howard MA et al. Comparison of laboriatory tests used for identification of the lupus anticoagulant. Am J Hematol 1989;30:213-20.
16. Petri M, Nelson L, Weimer F et al. The automated modified Russell viper venom time test for the lupus anticoagulant. J Rheumatol 1991;18:1823-5.
17. Lecher K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis: a study of 25 cases and review of the literature. Haemostasis 1985;15:254-62.
18. Bick RL, Baker WF. Anticardiolipin antibodies and thrombosis. Hematol Oncol Clin North Am 1992;6:1287-99.
19. Shi W, Krilis SA, Chong BH et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990;20:231-6.
20. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991:49:193-280.
21. Harris EN, Chan JKH, Asherson RA et al. Thrombosis recurrent fetal loss, and thrombocytopenia. Arch Intern Med 1986;146:2153-6.
22. Alegre VA, Gastineau DA, Winkelmam RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989;120:419-29.
23. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8
24. Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis: a study of 25 cases and review of the .literature. Haemostasis 1985;15:254-62.
25. Brey RL, Hart RG, Sherman DG et al. Antiphospholipid antibodies and cerebral ischemia in young people. Arthritis Rheum 1994;37:568-71.
26. Out HJ, Kooijman CD, Bruinse HW et al. Histopathological findings in placentae from patients with intrauterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol 1991;41:179-86.
27. Khamashla MA, Cuadrado MJ, Mujic F et al. The management of trrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-7.
28. Puig JC, Schmerling RA, Trevisani VFM, Prado GF. Anticoagulante ou Trombosante Lúpico. Diagnóstico & Tratamento 1998;3(4):34-6.